COVID-19
As data pours in from around the word, it’s clear Omicron is ending the pandemic

That light at the end of the tunnel is getting brighter and brighter.
In the United Kingdom where the Omicron wave is about 2 to 3 weeks ahead of North America, the Chair in Infection and Global Health at the University of Liverpool says the UK is entering “a new Covid-era”, which he says is “the beginning of the end”. The Chair in Infection and Global Health goes on to say “life in 2022 will be almost back to before the pandemic”.
This informative graph which he explains in depth in the video, John Campbell shows how as the cases of Omicron are at least 300% higher than at the peak of the pandemic, other metrics including hospitalizations, deaths, and patients ventilated are FAR lower than the peak.
As John Campbell shows us in this video presentation, there is a lot of reason to be optimistic about the very near future! As always Campbell includes links to the sources of his data as well as the names and positions of those he is quoting. This is included below the video.
https://ourworldindata.org/covid-metr…
Marco Cavaleri, EMA head of biological health threats and vaccines strategy https://www.ema.europa.eu/en/events/e… https://www.ema.europa.eu/en/events/e…
Boosters, can be done once, or maybe twice, but it’s not something that we can think should be repeated constantly. We need to think about how we can transition from the current pandemic setting to a more endemic setting. With omicron there will be a lot of natural immunity taking place on top of vaccination, We will be fastly moving to a scenario which is close to endemicity
Fourth dose for all Data has not yet been generated to support this approach. Repeated vaccinations in a short time frame will not represent a sustainable long term strategy
Endemic Covid, very soon https://www.bbc.co.uk/news/health-599… Omicron, endemic Consistent and predictable, not boom and bust Common colds, influenza, HIV, measles, malaria, tuberculosis
A new Covid-era Prof Julian Hiscox, Chair in Infection and Global Health, University of Liverpool UK, New and Emerging Respiratory Virus Threats Advisory Group
We’re almost there, it is now the beginning of the end, at least in the UK. I think life in 2022 will be almost back to before the pandemic. Should a new variant or old variant come along, for most of us, like any other common cold coronavirus, we’ll get the sniffles and a bit of a headache and then we’re OK
If you’re willing to tolerate zero deaths from Covid, then we’re facing a whole raft of restrictions and it’s not game over in a bad flu season, 200-300 die a day over winter and nobody wears a mask or socially distances, that’s perhaps a right line to draw in the sand
Dr Elisabetta Groppelli, virologist, St George’s, University of London
I am very optimistic We’ll soon be in a situation where the virus is circulating, we will take care of people at risk, but for anybody else we accept they will catch it – and your average person will be fine We need to accept the fact that our flu season is also going to be a coronavirus season, and that is going to be a challenge for us However, it is still uncertain how bad winters will be as the people who die from flu and Covid tend to be the same (You can’t die twice)
Prof Azra Ghani, epidemiologist, Imperial College London
Covid will still be around, but that we no longer need to restrict our lives. It seems like it’s taken a long time, but only a year ago we started vaccinating and we’re already an awful lot freer because of that. A new variant that can outcompete Omicron and be more pathogenic.
Prof Eleanor Riley, immunologist, University of Edinburgh
When Omicron has finished and moved through, immunity in the UK will be high, at least for a while.
Brownstone Institute
Curious: Angela Merkel’s September 2019 Visit to Wuhan

From the Brownstone Institute
BY
In a much-tweeted soundbite from the recent Congressional hearing on the origins of Covid-19, former CDC director Robert Redfield noted that three unusual events occurred in Wuhan in September 2019 suggesting a lab leak from the Wuhan Institute of Virology (WIV).
But another, in retrospect, highly curious event also occurred in Wuhan in September 2019: namely, none other than then German Chancellor Angela Merkel paid a visit to the city and, more specifically, to the Tongji Hospital on the left bank of the Yangtze River. The hospital is also known as the German-Chinese Friendship Hospital.
The below photo from Germany’s Deutsche Presse Agentur shows Chancellor Merkel being greeted by nurses at the hospital reception on September 7, 2019. (Source: Süddeutsche Zeitung.)

A 2021 House Foreign Affairs Committee Minority Report, referring in greater detail to the same events as Redfield, concludes that a lab leak took place at the WIV sometime prior to September 12, when, notably, the WIV’s virus and sample database was mysteriously taken offline in the middle of the night (p. 5 and passim).
What an incredible coincidence that the German Chancellor was visiting Wuhan’s Tongji Hospital at almost precisely the time when, according to Redfield’s speculations, a potentially catastrophic event was taking place across the river at the Wuhan Institute of Virology! This was, moreover, merely three months before the first officially acknowledged cases of Covid-19 began to turn up in the city.
But the coincidence is in fact even more incredible. For when those first cases did begin to turn up in Wuhan in early December 2019, they did not in fact turn up in the vicinity of the Wuhan Institute of Virology on the right bank of the Yangtze, but rather in the direct vicinity of Tongji Hospital on the left bank!
The below mapping of the initial cluster of cases from Science magazine makes this clear. The black dot is the epicenter of the cluster. Cross #5 marks the location of Tongji Hospital.

And that is not all. As discussed in my earlier article on “The Other Lab in Wuhan,”although the WIV was relatively far removed from the outbreak – say around 10 kilometers from the epicenter as the crow flies — there is in fact another virus research lab in Wuhan that is located right in the area of the initial cluster.
The lab in question is the German-Chinese Joint Laboratory of Infection and Immunity – or, as its German co-director Ulf Dittmer has also called it, the “Essen-Wuhan Laboratory for Virus Research” – and the Chinese host institution of the German-Chinese Joint Lab is none other than the Tongji-Hospital-affiliated Tongji Medical College.
Per Google maps, Tongji Medical College is located around one kilometer due north of the hospital. Have another look at the above map keeping in mind the indicated scale. This would put it nearly right at the epicenter of the outbreak!
According to German and Chinese sources, however, the lab is in fact located at another hospital affiliated with Tongji Medical College: Wuhan Union Hospital. The location of Union Hospital is marked by cross #6 on the Science map: still in the cluster, but a bit further away from the epicenter.
A press release on the website of the University of Duisburg-Essen, the German co-sponsor of the lab, notes that:
The Joint Lab is fully equipped for virus research. It is a BSL2 safety laboratory with access to BSL3 conditions. German and Chinese members of the lab have access to a large sample collection form [sic.] patients of the Department of Infectious Diseases for their research.
BSL stands for “biosafety level.”
The below photo from a German article on the Essen-Wuhan collaboration shows the virologist Xin Zheng of Union Hospital, Tongji Medical School, at work in the joint lab. Per the cited source, Xin did her doctorate at the University of Duisburg-Essen.

Could SARS-CoV-2 have leaked from the joint lab?
And, while we’re at it, was gain-of-function research being conducted at the lab? We do not know, but we do know that the German members of the lab will, at any rate, have been in contact with a nearby lab where it was being conducted. For the Wuhan Institute of Virology lists the University of Duisburg-Essen as one of its partner institutions.

Furthermore, in addition to its own partnership with the University of Duisburg-Essen, Tongji Medical College also has a longstanding academic exchange program with the Charité research and teaching hospital in Berlin of none other than Christian Drosten: the German virologist whose controversial and ultrasensitive PCR protocol, in effect, guaranteed that the Covid-19 outbreak would acquire the status of a “pandemic.”
As discussed in “The Other Lab in Wuhan,” Drosten appears as one of the scientists participating in the so-called “Fauci emails,” and of all the participants, he is the most vehement denier of the possibility of a lab leak.
In remarks in the German press, Drosten has admitted that he began working on his Covid-19 testing protocol before any Covid-19 cases had even officially been reported to the WHO! He says he did so based on information he had from unnamed virologist colleagues working in Wuhan. (Source: Die Berliner Zeitung.)
Speaking of which, Drosten can be seen below in the company of none other than Shi Zhengli of the Wuhan Institute of Virology, the scientist whose research on bat coronaviruses is suspected of being at the origin of a Covid-19 lab leak.

The picture comes from a “Sino-German Symposium on Infectious Diseases” that took place in Berlin in 2015 and that was organized by Ulf Dittmer of the University of Duisburg-Essen. Dittmer, as noted above, is the co-director of the Essen-Wuhan lab, which would be founded two years later. The symposium was funded by the German Ministry of Health.
Dittmer is the bald man with the striped shirt in the full group picture of symposium participants below. (Source: University of Duisburg-Essen.) The jovial bearded man with the bowtie in the next row is none other than Thomas Mertens, the current chair of the “Standing Committee on Vaccination” of the German health authority, the Robert Koch Institute.

The Berlin symposium was held one year after the US government declared a moratorium on gain-of-function research.
As it so happens, Drosten himself has been involved in gain-of-function research, as the below screen shot from the webpage of the German RAPID project makes clear.

RAPID stands for “Risk Assessment in Prepandemic Respiratory Infectious Diseases.” Further information from the German Ministry of Education and Research expressly states that Drosten’s Charité hospital does not merely oversee, but is directly involved (beteiligt) in RAPID sub-project 2: i.e. “identification of host factors by loss-of-function and gain-of-function experiments.”
Imagine for a moment that then President Donald Trump paid a visit to Wuhan in September 2019, at the very time that a lab leak is suspected to have occurred in the city.
And imagine that, while there, he made a stop at a hospital that is affiliated with a medical school located in the very epicenter of the Covid-19 outbreak that would officially occur three months later.
Imagine that this medical school, furthermore, runs a joint, BSL-3 capable, virus research lab with an American university – let’s say, for example, Ralph Baric’s University of North Carolina – and that Baric and his colleagues were themselves conducting research right in Wuhan!
And imagine that the American university in question is also a partner institution of the Wuhan Institute of Virology (Baric’s University of North Carolina is not in fact) and that the local Wuhan medical school also has a partnership with, say, the NIH.
And imagine that there is even a photo of none other than Anthony Fauci of the NIH with none other than Shi Zhengli of the Wuhan Institute of Virology at a joint “Sino-American Symposium on Infectious Diseases” in Washington that was organized by Baric and funded by the US Department of Health four years before the Covid-19 outbreak. And imagine, for good measure, that, say, Rochelle Walensky was also present at the event.
Imagine, finally, that Fauci had not just (allegedly) provided funding for gain-of-function research, but was himself directly involved in it.
The above concatenation of circumstances would undoubtedly be regarded as what some members of the US intelligence community might call “slam-dunk” proof of US complicity in any lab leak of the SARS-CoV-2 virus that may have occurred in Wuhan.
Why does the ample evidence of manifold German connections to and indeed involvement in virus research in Wuhan not merit at least the same degree of scrutiny, if not to say of certainty?
Brownstone Institute
The Vaccine Was “95% Effective” How?

From the Brownstone Institute
BY
The 1840 Treaty of Waitangi between the British Crown and Maori chiefs was a landmark event in the history of New Zealand. Drafted in English, a Maori translation was prepared, ostensibly to ensure that Maori could have an accurate understanding of the terms. In retrospect, it is less clear that a meeting of the minds was intended:
The English and Māori texts differ. As some words in the English treaty did not translate directly into the written Māori language of the time, the Māori text is not a literal translation of the English text. It has been claimed that Henry Williams, the missionary entrusted with translating the treaty from English, was fluent in Māori and that far from being a poor translator he had in fact carefully crafted both versions to make each palatable to both parties without either noticing inherent contradictions.
“The covid vaccine is 95% effective” is a contemporary Treaty of Waitangi. The original is in the language of clinical trials. It was never translated. The public interpreted this phrase in their native language, normal English. What Pfizer said and what the public heard were quite different. The public would have been far more skeptical of these products had the clinical trial results been translated into normal English.
What we need is a proper translation and an explanation of how miscommunication happened.
The Injections Did Not Stop Infection
By now, everyone knows that the Pfizer and Moderna products did not stop people from getting Covid. Covid disease has mowed a wide strip through the double and triple-masked talking heads who told everyone that the shots would make them immune.
What is less well known is that:
- The products were never expected to stop infection or transmission.
- The clinical trials did not test for their ability to do so.
A clinical trial is designed to test a drug for effectiveness, which is strictly defined by one or more endpoints. An endpoint is a measurable outcome that can be assessed for each participant. With that in mind, prevention of infection was not an endpoint of the BioNTech/Pfizer injection clinical trials. And, this was known in 2020 before the products were approved for emergency use and distributed to the public starting in 2021.
In this New England Journal of Medicine research summary, Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine, under Limitations and Remaining Questions, we find that “whether the vaccine protects against asymptomatic infection and transmission to unvaccinated persons” remains unanswered by the clinical trial.
What did the clinical trial test for, if not the ability of the mRNA vaccine to stop transmission and/or infection? The trial was designed to test the ability of the injections to prevent “symptomatic Covid 19 cases” defined as one or more of a number symptoms and a positive test (see page 7 of the supplementary appendix for details).
@pfizer tweeted in Jan 2021 that stopping transmission was their “highest priority”. Their product does not do that, nor did the tweet make a claim that it did so. But it was their highest priority nonetheless. That, and getting as many people injected as possible.

Failure to Prevent Infection Was Known Before the Rollout
In October 2022, a Pfizer executive testified to an EU body that Pfizer had not tested the ability of the vaccine to stop transmission. This story was shocking to some and generated accusations that Pfizer had lied about the capabilities of the shots. But this information had been available since the trial results were released early in 2021. Pfizer had already been criticized for this.
Dr William A Haseltine PhD, wrote in Forbes in September 2020:
What would a normal vaccine trial look like?
One of the more immediate questions a trial needs to answer is whether a vaccine prevents infection. If someone takes this vaccine, are they far less likely to become infected with the virus? These trials all clearly focus on eliminating symptoms of Covid-19, and not infections themselves. Asymptomatic infection is listed as a secondary objective in these trials when they should be of critical importance.
On October 21, 2020 the editor of the BMJ (British Medical Journal) Peter Doshi asked:
Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, said, “Ideally, you want an antiviral vaccine to do two things . . . first, reduce the likelihood you will get severely ill and go to the hospital, and two, prevent infection and therefore interrupt disease transmission.”
Yet the current phase III trials are not actually set up to prove either. None of the trials currently underway are designed to detect a reduction in any serious outcome such as hospital admissions, use of intensive care, or deaths. Nor are the vaccines being studied to determine whether they can interrupt transmission of the virus….
Is It Even a Vaccine?
A vaccine that prevents infection is known as “neutralizing” or “sterilizing”. I am a software engineer with no training in medicine, pharmacology or clinical trials. I consider myself a good barometer of what the average untrained person would think about such things. Prior to 2021 I had thought that immunity was a necessary condition for a drug to earn the title of “vaccine”. If anyone had asked me, I would have told them that the Covid injections were a treatment, not a vaccine.
The Wikipedia article about vaccines (Mar 5 2023) aligns with my untrained understanding:
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. … A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future.
Cornell Law provides the following legal definition of vaccine, sourcing 26 USC § 4132(a)(2), which is consistent with the above:
The term “vaccine” means any substance designed to be administered to a human being for the prevention of 1 or more diseases.
The definition published by the CDC prior to 2021 said much the same. But the CDC website changed the definition on or after August 2021. The older version found on the internet archive is here (emphasis added):
Immunity: Protection from an infectious disease. If you are immune to a disease, you can be exposed to it without becoming infected.
Vaccine: A product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease.
Here is the new version (emphasis added):
Vaccine: A preparation that is used to stimulate the body’s immune response against diseases.
The earlier pair of definitions is quite easy to understand. The latter, much more difficult. What exactly is a “preparation”? Does a vaccine stimulate the body or only prepare the body? What is or is not a vaccine according to the new definition?
While the CDC may think that they can change the meanings of words whenever they like, public memory retains the original meaning. The assumption of immunity permeates almost all non-expert level discussion of vaccines. A web search for “why are vaccines good” shows results that assume or imply immunity.
Even the CDC did not finish the job of memory-holing the old language. On the very same CDC website, under 5 Reasons It Is Important for Adults to Get Vaccinated, we read “By getting vaccinated, you can protect yourself and also avoid spreading preventable diseases to other people in your community.” And then, “Vaccines Can Prevent Serious Illness”.
The timing of the CDC’s edit suggests to me that prior to 2021, the CDC had the same understanding of vaccines as I do. I believe that they wanted a new definition because they knew that the products being developed at warp speed were not vaccines in the original sense of the word. And it was important that those products be called “vaccines” for reasons that I will explain later. This incident brings to mind a meme that I no longer have a link to. captioned: “We changed what ‘definition’ means so you can’t say that we redefined anything.”
What Does “95% Effective” Mean?
The “95% effective” message was repeated in nearly all reporting on the clinical trials. But the question, “effective at doing what?” was rarely asked. To answer this requires walking down the links of a chain of terminology from the world of clinical trials.
The first link in the chain is “risk”. Risk is the probability of a bad outcome. These are assumed to happen randomly within a group. A clinical trial must define in advance the bad outcomes that the drug intends to avoid. The next link is “endpoint”. Each distinct bad outcome is an “endpoint”. The trial compares the endpoints between a control group who did not take the drug and a test group, who did.
The purpose of a clinical trial is to determine the ability of a drug to reduce risk. A drug that reduces risk is “effective”. There are two ways of quantifying risk reduction. From the NIH glossary:
Absolute risk reduction (ARR) or risk difference
the difference in the incidence of poor outcomes between the intervention group of a study and the control group. For example, if 20 per cent of people die in the intervention group and 30 per cent in the control group, the ARR is 10 per cent (30–20 per cent).
Relative risk (RR)
the rate (risk) of poor outcomes in the intervention group divided by the rate of poor outcomes in the control group. For example, if the rate of poor outcomes is 20 per cent in the intervention group and 30 per cent in the control group, the relative risk is 0.67 (20 per cent divided by 30 per cent).
The difference between the ARR and RR (also known as “RRR”, to align with ARR) is in the denominator. The ARR divides by the number of participants in one of the groups. The RRR divides by the number of people with bad outcomes in the control group – a necessarily much smaller number.
The ARR is the number most relevant for a drug – such as the Pfizer injections – that was to be given to everyone. But the RRR is the preferred method of presentation for pharma when they want to exaggerate the effectiveness of a drug because it will always be a much larger number. Would you take a drug that could reduce the incidence of a rare disease by 50%? From 10 per 1 million to 5 per 1 million is an 50% RRR and an 0.0005% ARR.
The 95% figure cited for the covid injections is the relative risk. The absolute risk reduction was 0.84%. In a slide deck from the Canadian Covid Care Alliance(CCCA), slide 11 shows how the 91% was achieved (it is 91%, not 95%, because the it refers to an earlier version of the study):

The research paper COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room puts the ARR in the 1% range. The CCCA slide deck gives an ARR of 0.84%, though it is not clear how they reached this number, based on the other numbers in their slides.
A clinical trial finding of a 1% ARR means that 99% of the people who take the drug either did not experience the condition that the drug treats, or they did experience it, but were not helped by the drug. The 1% both had the condition and were helped by the drug. Another way of saying this is the Number Needed to Treat (NNT). NNT is the reciprocal of the ARR and is the number of people who must take the drug to help one person reach the endpoint. An ARR of 1% corresponds to an NNT of 100 people.
We can now answer the question of the meaning of vaccine effectiveness. The endpoint of the trial was a severe confirmed case of covid at least 7 days after the second dose. This endpoint requires the participant in the trial to have covid symptoms and a positive covid test. “95% effective” means that 95% of the patients who had Covid symptoms and a positive test were in the control group. Five percent were in the test group.
Here’s what “95% effective” did not mean: if you take the shots, then you will have a 95% lower chance of getting covid. But that is how most people understood it because that is what the words mean in normal English.
Then the Lying Started
Once the public had their hopes raised by the false translation of the “95% effective” message, the pandemic-industrial-complex went into high gear to amplify it. They stated the incorrect message loudly, frequently, and as if it were fact. The injections would – with 100% certainty (perhaps 200%) – protect you from infection. Many of the people who said this were doctors or scientific researchers who must have understood how to interpret clinical trials.
Here are some choice quotes that did not age well:
- “You’re not going to get Covid if you have these vaccinations.” Joe Biden, CNN Town Hall July 2021
- “Now we know that the vaccines work well enough that the virus stops with every vaccinated person. A vaccinated person gets exposed to the virus, the virus does not infect them, the virus cannot then use that person to go anywhere else,” she added with a shrug. “It cannot use a vaccinated person as a host to go get more people. [Vaccines] will get us to the end of this.” – Rachel Maddow, March 2021
- “When people are vaccinated they can feel safe that they won’t get infected, whether they’re outdoors or indoors.” – Dr. Anthony Fauci, May 2021(outdoors: seriously?)
- “Vaccination against COVID-19 prevents breakthrough infections, Stanford researchers find.” – Stanford Medicine, July 2021
- Vaccinated people become “dead ends” for the virus – Anthony Fauci, May 2021
Demonizing the Unvaxxed
The public has consistently over-estimated the infection fatality rate of Covid. Some even believed the fatality rate to be above 10%. They believed that we were in great danger. They also believed that the “95% effective” vaccine would bring the pandemic to a quick end, once everyone had taken it. Anyone who refused to do so was therefore risking not only their own life, but everybody else’s as well.
Dr Anthony Fauci estimated herd immunity would emerge when around 60% of the population had taken the vaccine … or perhaps 70, 80, no wait … 85%. Or maybe 100% (which would include large numbers who already had natural immunity). Bill Gates extended that to everyone on earth.
The narrative then turned to demonization of those who refused to submit to vaccine coercion. The selfish anti-social behavior of the anti-vaxxers with their stubborn attachment to “free dumb” that was keeping everyone locked indoors and forcing us all to wear diapers on our faces. Yale University behavioral researchers tested messaging strategies to determine whether shame, embarrassment or fear was most effective.
President Biden said that we the nation was experiencing a “pandemic of the unvaccinated”. Later, Biden ominoulsy warned the unvaccinated that he had been waiting a long time for them to get injected, but “our patience is wearing thin”. In December of 2021 the White House issued a cheery year end greeting to the vaccinated. The unvaccinated, on the other hand, were “looking at a winter of severe illness and death.” Merry Christmas.
Even South Park, which I consider a reliable source of contrarian political opinion, ran a storyline set in the year 2050 in which every single character had to be vaccinated for the 30-year pandemic to end. This episode featured one lone holdout who would not get vaccinated due to a crustacean allergy i.e. for “shellfish reasons”. This gag took aim at people who considered the vaccine to be a violation of body autonomy, and those who objected to components used in its development for religious reasons, thereby scoring a “two for one”.
Volumes can, and will, be written about the intense onslaught of propaganda aimed at getting two needles in every deltoid. I will provide one more example that represents no more than the median level of insanity; plenty of people called for the same or worse. @ClayTravis, in February 2023, tweeted the results of a Rasmussen poll from 2022:
Last January 60% of Democrats wanted to lock everyone who didn’t get the covid shot in their houses. Over 40% of Democrats wanted those who rejected the covid shot sent to quarantine camps. Over 40% also wanted anyone who criticized the covid shot fined & imprisoned. Over a quarter wanted those who didn’t get the covid shot to have their kids seized.
While there were many agendas driving the madness, the Treaty of Waitangi effect was a critical part in carrying it out. If the message had been that “everyone is going to get exposed to covid – injected or not”, then it could not have happened. The misunderstanding convinced the public that mass vaccination would stop the pandemic; and that the holdouts were prolonging it. Without this belief, none of the coercion made any sense: employment mandates, school mandates, quarantine camps, or vaccine passports. As the hysteria fades, the last remaining mandates are being dropped as the reality sinks in that the shots do not stop the spread.
Welcome to Waitangi World. I hope that you have a pleasant stay.
-
Business1 day ago
Chief Clarence Louie and author Matt Tenney featured at Workforce Strategies Summit March 30 in Red Deer
-
City of Red Deer2 days ago
G.H. Dawe expansion project complete
-
International2 days ago
China’s Xi meeting Putin in boost for isolated Russia leader
-
Health2 days ago
Poilievre calls for testing that would allow doctors, nurses to work across Canada
-
International1 day ago
Putin welcomes China’s Xi to Kremlin amid Ukraine war
-
Crime1 day ago
With overdoses up, states look at harsher fentanyl penalties
-
Business1 day ago
Amazon to lay off 9,000 employees on top of 18,000 in Jan.
-
Business1 day ago
Fed’s tough challenge: Confront inflation and bank jitters